PL4 Novel Insights in Adipocyte Signaling and Impact on Clinical Care

Program: Plenary
Translational Session
Saturday, April 2, 2016: 3:30 PM-4:30 PM
Hall B2 (BCEC)

White fat, brown fat, no fat, beige:  From Two Nobels for fatty acids and a fatty hormone to multiple signals and strategies in obesity and lipodystrophy

 

3:30 PM
Lisa H Fish, MD, Hennepin County Medical Ctr, Edina, MN
Nothing to Disclose: LHF
3:40 PM
Ormond A MacDougald, PhD, Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI
Nothing to Disclose: OAM
4:05 PM
Steven Kyle Grinspoon, M.D., Program in Nutritional Metabolism, Massachusetts General Hospital/Harvard Medical School, Boston, MA
Disclosures:
SKG: Consultant, Gilead, Consultant, Bristol-Myers Squibb, Consultant, Merck & Co., Speaker, Takeda, Consultant, Navidea, Consultant, Theratechnologies.
See more of: Plenary

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire